AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34126052 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site access to oral PrEP
Number of subjects: 2124
Study 34126052 — intervention group
Group type: COMPARATOR
Intervention: No on-site access to oral PrEP (before access)
Number of subjects: 2124
Study 34126052 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site access to oral PrEP (within 180 days after access)
Number of subjects: 2124
Study 34126052 — intervention group
Group type: COMPARATOR
Intervention: No on-site access to oral PrEP (within 180 days before access)
Number of subjects: 2124
Study 35405944 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic intervention (Bifidobacterium longum R0175, Lactobacillus helveticus R0052, Lactiplantibacillus plantarum R1012)
Number of subjects: 22
Study 35405944 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 22
Study 32576828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet (FMD)
Number of subjects: 131
Study 32576828 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 131
Study 36498313 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted swimming activity (exercise intervention)
Number of subjects: 40
Study 36498313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33715937 — intervention group
Group type: EXPERIMENTAL
Intervention: Crestal level (CL) implants
Number of subjects: 22
Study 33715937 — intervention group
Group type: COMPARATOR
Intervention: Supracrestal level (SL) implants
Number of subjects: 22
Study 36002047 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge-to-edge repair (TEER)
Number of subjects: 144
Study 36002047 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 144
Study 36002047 — intervention group
Group type: EXPERIMENTAL
Intervention: TEER
Number of subjects: 144
Study 33023487 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS treatment for upper limb recovery
Number of subjects: 13
Study 36128937 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene intervention (IG)
Number of subjects: 191
Study 36128937 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 191
Study 32394757 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention
Number of subjects: 0
Study 32394757 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32567472 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion of a dual mobility cup (DMC)
Number of subjects: 1600
Study 32567472 — intervention group
Group type: COMPARATOR
Intervention: Standard cup (control group)
Number of subjects: 1600
Study 36223321 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic proximal gastrectomy (LPG) with gastric tube reconstruction
Number of subjects: 0
Study 36223321 — intervention group
Group type: COMPARATOR
Intervention: Total gastrectomy (TG)
Number of subjects: 0
Study 36223321 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study 32807159 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine consultation service and standardized operating procedures in network hospitals
Number of subjects: 0
Study 32807159 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized operating procedures and multiprofessional training scheme
Number of subjects: 0
Study 32807159 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality management program
Number of subjects: 0
Study 36385713 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical melatonin (25 mg/g) applied twice daily during radiation therapy
Number of subjects: 65
Study 36385713 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied twice daily during radiation therapy
Number of subjects: 65
Study 33402034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential-with-tracing presentation of instructional arrows
Number of subjects: 0
Study 33402034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential-without-tracing presentation of instructional arrows
Number of subjects: 0
Study 33402034 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous presentation of instructional arrows
Number of subjects: 0
Study 33402034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential presentation of arrows (both types)
Number of subjects: 0
Study 32890808 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral rigid laryngeal endoscopy (TORLE)
Number of subjects: 96
Study 32890808 — intervention group
Group type: COMPARATOR
Intervention: Transnasal flexible fiberoptic laryngoscopy (TNFFL)
Number of subjects: 96
Study 34921654 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-ecological aggression prevention program
Number of subjects: 2042
Study 33718317 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive treatment intervention targeting household members of clinical malaria cases
Number of subjects: 0
Study 33718317 — intervention group
Group type: COMPARATOR
Intervention: Intervention units defined according to shared sleeping spaces and household membership
Number of subjects: 0
Study 33718317 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporating local definitions and community preference in trial design
Number of subjects: 0
Study 32075590 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism Adaptation (PA) treatment
Number of subjects: 42
Study 32075590 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 42
Study 35871424 — intervention group
Group type: EXPERIMENTAL
Intervention: Video modeling tooth-brushing education
Number of subjects: 137
Study 33951328 — intervention group
Group type: EXPERIMENTAL
Intervention: A VitD group (800 mg calcium and 0.5 μg active vitamin D)
Number of subjects: 420
Study 33951328 — intervention group
Group type: EXPERIMENTAL
Intervention: P-A VitD group (800 mg calcium, 0.5 μg active vitamin D, and physical exercise)
Number of subjects: 420
Study 33951328 — intervention group
Group type: EXPERIMENTAL
Intervention: P-NA VitD group (800 mg calcium, 800 IU non-active vitamin D, and physical exercise)
Number of subjects: 420
Study 33951328 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control groups)
Number of subjects: 420
Study 35665521 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg t.i.d.
Number of subjects: 60
Study 35665521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33653635 — intervention group
Group type: EXPERIMENTAL
Intervention: mpMRI for possible MIBC (Likert 3-5)
Number of subjects: 100
Study 33653635 — intervention group
Group type: COMPARATOR
Intervention: TURBT
Number of subjects: 100
Study 33653635 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-point Likert scale
Number of subjects: 100
Study 33653635 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy biopsies
Number of subjects: 100
Study 32146471 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine-Tipiracil (FTD/TPI)
Number of subjects: 0
Study 32146471 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 0
Study 32146471 — intervention group
Group type: EXPERIMENTAL
Intervention: Rechallenge with previous treatment lines
Number of subjects: 0
Study 32146471 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized approaches based on comprehensive molecular profiling
Number of subjects: 0
Study 34465252 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF 240 mg twice daily
Number of subjects: 1736
Study 34465252 — intervention group
Group type: COMPARATOR
Intervention: PBO/DMF
Number of subjects: 1736
Study 34465252 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF/DMF
Number of subjects: 1736
Study 34465252 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF
Number of subjects: 1736
Study 33951595 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated rice-duck (RD) system
Number of subjects: 180
Study 33951595 — intervention group
Group type: COMPARATOR
Intervention: Floor pen rearing (FPR) system
Number of subjects: 180
Study 35579605 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 226
Study 35579605 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 226
Study 32863014 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculoacupuncture
Number of subjects: 68
Study 32863014 — intervention group
Group type: COMPARATOR
Intervention: Control (metoclopramide)
Number of subjects: 68
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: SS+CH
Number of subjects: 55
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: FS+CH
Number of subjects: 55
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: SH+CH
Number of subjects: 55
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: SS+MTA
Number of subjects: 55
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: FS+MTA
Number of subjects: 55
Study 35799339 — intervention group
Group type: EXPERIMENTAL
Intervention: SH+MTA
Number of subjects: 55
Study 35799339 — intervention group
Group type: COMPARATOR
Intervention: CH
Number of subjects: 55
Study 35799339 — intervention group
Group type: COMPARATOR
Intervention: MTA
Number of subjects: 55
Study 34004092 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 526
Study 32980725 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic models derived from T1C alone
Number of subjects: 490
Study 32980725 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of T1C and T2
Number of subjects: 490
Study 35001564 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS)
Number of subjects: 7
Study 35001564 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine HCl (DH)
Number of subjects: 7
Study 35001564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 7
Study 33589391 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 35126568 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of Zintoma (ginger rhizome) capsules
Number of subjects: 128
Study 35126568 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg Zintoma capsules
Number of subjects: 128
Study 35126568 — intervention group
Group type: COMPARATOR
Intervention: 500 mg placebo capsules (containing chickpea flour)
Number of subjects: 128
Study 35126568 — intervention group
Group type: COMPARATOR
Intervention: 250 mg placebo capsules
Number of subjects: 128
Study 35986257 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aspiration
Number of subjects: 142
Study 35986257 — intervention group
Group type: EXPERIMENTAL
Intervention: Forceps biopsy
Number of subjects: 142
Study 35986257 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modalities (needle aspiration and forceps biopsy)
Number of subjects: 142
Study 34621271 — intervention group
Group type: EXPERIMENTAL
Intervention: B cell depleting therapy (anti-CD20 treatment)
Number of subjects: 30
Study 34621271 — intervention group
Group type: COMPARATOR
Intervention: B cell depleting therapy (rituximab vs ofatumumab)
Number of subjects: 30
Study 33788482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partitioned moxibustion
Number of subjects: 64
Study 33788482 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron hydrochloride intravenous (Control)
Number of subjects: 64
Study 35483400 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment (self-administered, escalating dosage up to 3 times per week for 4-6 months)
Number of subjects: 110
Study 35483400 — intervention group
Group type: COMPARATOR
Intervention: Surgery (excision or ablation)
Number of subjects: 110
Study 35483400 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 110
Study 35483400 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 110
Study 34360360 — intervention group
Group type: EXPERIMENTAL
Intervention: Active music intervention
Number of subjects: 90
Study 34360360 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptive music intervention
Number of subjects: 90
Study 34360360 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 90
Study 32072388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 855
Study 32072388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 855
Study 32072388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram evaluation using AUC and calibration plots
Number of subjects: 855
Study 32072388 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA)
Number of subjects: 855
Study 36083023 — intervention group
Group type: EXPERIMENTAL
Intervention: Narration (describing the memory out loud)
Number of subjects: 0
Study 36083023 — intervention group
Group type: COMPARATOR
Intervention: Imagery (recalling the memory silently)
Number of subjects: 0
Study 32492148 — intervention group
Group type: COMPARATOR
Intervention: Step 1 diet (30%E fat, 9% SFA)
Number of subjects: 188
Study 32492148 — intervention group
Group type: COMPARATOR
Intervention: Low-Sat diet (26%E fat, 5% SFA)
Number of subjects: 188
Study 32492148 — intervention group
Group type: COMPARATOR
Intervention: High-MUFA diet (37%E fat, 8% SFA, 22% MUFA)
Number of subjects: 188
Study 35813289 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalation with manual infusion of remifentanil
Number of subjects: 82
Study 35813289 — intervention group
Group type: COMPARATOR
Intervention: Effect-site target-controlled infusion of propofol and remifentanil
Number of subjects: 82
Study 33621601 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (100 mg subcutaneously twice daily for up to 5 days)
Number of subjects: 42
Study 33621601 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) alone
Number of subjects: 42
Study 36335033 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical warm-up using a virtual reality simulator (priming arm)
Number of subjects: 151
Study 36335033 — intervention group
Group type: COMPARATOR
Intervention: Usual preparatory routine for surgery (control arm)
Number of subjects: 151
Study 34321045 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with inherited cardiac disorders
Number of subjects: 214
Study 34321045 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (age and gender-matched control group)
Number of subjects: 214
Study 32961293 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaggery-based biofloc system (JB-BFT) at C:N12, C:N15, C:N20
Number of subjects: 0
Study 32961293 — intervention group
Group type: COMPARATOR
Intervention: Control group (no carbon source)
Number of subjects: 0
Study 36148702 — intervention group
Group type: EXPERIMENTAL
Intervention: Exo4Work PSE support
Number of subjects: 0
Study 36148702 — intervention group
Group type: COMPARATOR
Intervention: No support (control)
Number of subjects: 0
Study 32452691 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Up, Stepping Out (SUSO) program
Number of subjects: 39
Study 32145678 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine 1 mg orally twice a day for 90 days
Number of subjects: 25
Study 32145678 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 25
Study 33541650 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-starch interaction
Number of subjects: 16
Study 33541650 — intervention group
Group type: COMPARATOR
Intervention: Gluten
Number of subjects: 16
Study 34062283 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC)
Number of subjects: 14
Study 34062283 — intervention group
Group type: COMPARATOR
Intervention: Concentric cycling (CON)
Number of subjects: 14
Study 36050407 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification decision tree model for GFR estimation
Number of subjects: 518
Study 34206346 — intervention group
Group type: EXPERIMENTAL
Intervention: Resisted Sprint Training (RST)
Number of subjects: 90
Study 34206346 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 90
Study 34206346 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 90
Study 32962422 — intervention group
Group type: COMPARATOR
Intervention: a‐tPCS at 4 Hz
Number of subjects: 15
Study 32962422 — intervention group
Group type: COMPARATOR
Intervention: c‐tPCS at 4 Hz
Number of subjects: 15
Study 32962422 — intervention group
Group type: COMPARATOR
Intervention: a‐tPCS at 75 Hz
Number of subjects: 15
Study 32962422 — intervention group
Group type: COMPARATOR
Intervention: c‐tPCS at 75 Hz
Number of subjects: 15
Study 35921997 — intervention group
Group type: EXPERIMENTAL
Intervention: New multilayer hypoallergenic coating system
Number of subjects: 120
Study 35921997 — intervention group
Group type: COMPARATOR
Intervention: Standard implant
Number of subjects: 120
Study 33518311 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary resistant potato starch (RPS) 12%
Number of subjects: 96
Study 33518311 — intervention group
Group type: COMPARATOR
Intervention: Control group (0% RPS)
Number of subjects: 96
Study 32527365 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification slips (NS standard of care)
Number of subjects: 442
Study 32527365 — intervention group
Group type: EXPERIMENTAL
Intervention: NS and text messages (SMS)
Number of subjects: 442
Study 32527365 — intervention group
Group type: EXPERIMENTAL
Intervention: NS and telephone calls
Number of subjects: 442
Study 32527365 — intervention group
Group type: COMPARATOR
Intervention: Control group (NS only)
Number of subjects: 442
Study 32527365 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall attendance
Number of subjects: 442
Study 32527365 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner non-treatment
Number of subjects: 442
Study 36107219 — intervention group
Group type: EXPERIMENTAL
Intervention: RT boost (80 Gy to the boost subvolume)
Number of subjects: 81
Study 36107219 — intervention group
Group type: COMPARATOR
Intervention: Standard RT (70 Gy)
Number of subjects: 81
Study 32822347 — intervention group
Group type: COMPARATOR
Intervention: Artemisinin-sensitive (ART-S) parasites
Number of subjects: 27
Study 32822347 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin-resistant (ART-R) parasites
Number of subjects: 27
Study 32822347 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate (AS) 2 mg/kg oral dose
Number of subjects: 27
Study 32651338 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg Dalfampridine extended release (D-ER)
Number of subjects: 377
Study 32651338 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Dalfampridine extended release (D-ER)
Number of subjects: 377
Study 32651338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377
Study 35971178 — intervention group
Group type: EXPERIMENTAL
Intervention: Online personalised parenting programme
Number of subjects: 433
Study 35971178 — intervention group
Group type: COMPARATOR
Intervention: Online factsheets about adolescent development and wellbeing
Number of subjects: 433
Study 32272171 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid phenotypic AST
Number of subjects: 116
Study 32272171 — intervention group
Group type: COMPARATOR
Intervention: Conventional AST
Number of subjects: 116
Study 35850588 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive art therapy (EAT) plus usual care (UC)
Number of subjects: 360
Study 35850588 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) only
Number of subjects: 360
Study 32865471 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-tempo music
Number of subjects: 0
Study 32865471 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-tempo music
Number of subjects: 0
Study 32865471 — intervention group
Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 0
Study 34699909 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS training
Number of subjects: 53
Study 34699909 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS training - Inquire element
Number of subjects: 53
Study 34699909 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS training - Mirror element
Number of subjects: 53
Study 34699909 — intervention group
Group type: EXPERIMENTAL
Intervention: AIMS training - Secure element
Number of subjects: 53
Study 34699909 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 53
Study 34699909 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-confidence
Number of subjects: 53
Study 34699909 — intervention group
Group type: COMPARATOR
Intervention: Standardized patient evaluations of communication skills
Number of subjects: 53
Study 33685375 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injectable
Number of subjects: 97
Study 33685375 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 97
Study 32055629 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled 0.9% normal saline by ultrasonic nebuliser with warming (UNW)
Number of subjects: 27
Study 32055629 — intervention group
Group type: COMPARATOR
Intervention: Oral expectorant treatment
Number of subjects: 27
Study 36254010 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led program
Number of subjects: 150
Study 36254010 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 150
Study 32421163 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (24-week program)
Number of subjects: 68
Study 32421163 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study 32690056 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery Simulation Teaching based on a Real Reconstruction Aid (RRA‐SST)
Number of subjects: 26
Study 32690056 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgical live teaching
Number of subjects: 26
Study 32690056 — intervention group
Group type: EXPERIMENTAL
Intervention: RRA‐SST
Number of subjects: 26
Study 33279662 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and placebo (PLA)
Number of subjects: 30
Study 33279662 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and BCAA (9 g/day)
Number of subjects: 30
Study 33279662 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 32437857 — intervention group
Group type: EXPERIMENTAL
Intervention: Single impression with stock trays (irreversible hydrocolloid)
Number of subjects: 52